Paola Gehrig
Overview
Explore the profile of Paola Gehrig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wickenheisser N, Dillon M, Broadwater G, Zacherl K, Bixel K, Levine M, et al.
Gynecol Oncol
. 2023 Nov;
179:70-78.
PMID: 37944328
Objective: To compare radical hysterectomy case volume, cancer stage, and biopsy-to-treatment time of invasive cervical cancer diagnosed before and after onset of the COVID-19 pandemic. Methods: In a multi-institution retrospective...
2.
Hathout L, Erickson B, Gehrig P, Harkenrider M, Klopp A, Small Jr W
Pract Radiat Oncol
. 2023 Jul;
13(6):551-557.
PMID: 37442429
No abstract available.
3.
Buckingham L, Janssen M, Ray E, Tucker K, Davidson B, Arenth J, et al.
J Palliat Med
. 2020 Jan;
23(5):712-718.
PMID: 31928374
Palliative care (PC) teams are increasingly being called upon to provide care earlier and more remote from end of life. Because much of the field has grown out of hospice...
4.
Puechl A, Edwards J, Suri A, Nakayama J, Bean S, Gehrig P, et al.
Gynecol Oncol
. 2019 Jan;
153(1):74-79.
PMID: 30661765
Background: Granulosa cell tumors (GCT) variably express estrogen receptors (ER) and progesterone receptors (PR). The goal of this study is to evaluate the relationship between ER and PR expression patterns...
5.
Shafer A, Gehrig P
Obstet Gynecol
. 2018 Dec;
133(1):233.
PMID: 30575674
Obstetrician-gynecologists often incorporate surgical procedures in the care of women. Each phase of a woman's life cycle presents different challenges regarding preoperative, intraoperative, and postoperative management. Appropriate workup and preparation...
6.
Starling B, Kumar P, Lucas A, Barrow D, Farnan L, Hendrix L, et al.
Cancer Chemother Pharmacol
. 2018 Oct;
83(1):61-70.
PMID: 30327876
Purpose: Obesity may alter mononuclear phagocyte system (MPS) function and the pharmacology and efficacy of nanoparticles therapies, such as PEGylated liposomal doxorubicin (PLD). We aimed to evaluate the relationships between...
7.
Madden A, Oberhardt B, Lockney D, Santos C, Vennam P, Arney D, et al.
Nanomedicine (Lond)
. 2017 Sep;
12(20):2519-2532.
PMID: 28952882
Aim: To compare the pharmacokinetics and efficacy of doxorubicin containing plant virus nanoparticles (PVNs) with PEGylated liposomal doxorubicin (PLD) and small molecule doxorubicin in two mouse models of cancer. Materials...
8.
Tran A, Gehrig P
F1000Res
. 2017 Feb;
6:81.
PMID: 28184290
Endometrial cancer is the most common gynecologic malignancy in the United States, with yearly rates continuing to increase. Most women present with early stage disease; however, advanced disease carries a...
9.
Davidson B, Foote J, Clark L, Broadwater G, Ehrisman J, Gehrig P, et al.
Gynecol Oncol Rep
. 2016 Jun;
17:3-6.
PMID: 27354990
The objective of this study is to evaluate the association between tumor grade and response to chemotherapy in patients with endometrioid endometrial adenocarcinoma. Patients with advanced or recurrent endometrioid endometrial...
10.
Ozen A, Falchook A, Varia M, Gehrig P, Jones E
Gynecol Oncol
. 2015 May;
138(2):429-33.
PMID: 26024766
Background: Clinical trials have helped refine management of early stage endometrial cancer (EC). For patients with intermediate risk features, adjuvant radiation is considered, primarily vaginal cuff brachytherapy. For higher risk...